Journal of medicinal and pharmaceutical chemistry 2012-04-12

Design of potent and selective hybrid inhibitors of the mitotic kinase Nek2: structure-activity relationship, structural biology, and cellular activity.

Paolo Innocenti, Kwai-Ming J Cheung, Savade Solanki, Corine Mas-Droux, Fiona Rowan, Sharon Yeoh, Kathy Boxall, Maura Westlake, Lisa Pickard, Tara Hardy, Joanne E Baxter, G Wynne Aherne, Richard Bayliss, Andrew M Fry, Swen Hoelder

Index: J. Med. Chem. 7th ed., 55 , 3228-3241, (2012)

Full Text: HTML

Abstract

We report herein a series of Nek2 inhibitors based on an aminopyridine scaffold. These compounds have been designed by combining key elements of two previously discovered chemical series. Structure based design led to aminopyridine (R)-21, a potent and selective inhibitor able to modulate Nek2 activity in cells.© 2012 American Chemical Society